Analyze Portfolio
Nasdaq · Healthcare

MeiraGTx Holdings plc (MGTX)

As-reported financials and recent SEC filings for MeiraGTx Holdings plc, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.

Snapshot

Revenue
$81.4M
Net income
$-114.2M
Net margin
-140.3%
Diluted EPS
$-1.42
ROE
1971.4%
P/E (TTM)
Market cap
Debt / equity

Income statement (as reported)

LineFY2025FY2024FY2023FY2021FY2021
Revenue$81.4M$33.3M$14.0M$15.9M$37.7M
Gross profit
Operating income$-106.0M$-164.2M$-137.1M$-116.4M$-72.8M
Net income$-114.2M$-147.8M$-84.0M$-129.6M$-79.6M
Diluted EPS$-1.42$-2.12$-1.49$-2.87$-1.80

Source: company XBRL financial statements on SEC EDGAR.

Recent SEC filings

Largest Healthcare peers

All Healthcare companies →

Go deeper on MGTX

Search MeiraGTx Holdings plc’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.

Start free

Or check your whole portfolio free — no account needed.

Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.